NCT04361305

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

Multicenter Study of the Efficacy and Safety of Dapoxetine Combined With Tadalafil in Men With Premature Ejaculation and Concomitant Erectile Dysfunction

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Yan-Ping Huang · Academic / Other
• Sex: Male
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Premature ejaculation (PE) is a common disease in the andrology clinic. Currently, the effectiveness and outcome differences of drug treatment still need to be studied and demonstrated. Premature ejaculation concurrent with erectile dysfunction (ED) is common in outpatient clinics. The preferred treatment plan for these patients still needs to be further studied and explored, and the difference in the efficacy of different treatment regiments remain to be evaluated.

Conditions

• Premature Ejaculation
• Erectile Dysfunction

Interventions

Type	Name	Description
DRUG	Dapoxetine	30 mg tablets 1 to 3 hours before sexual activity prn (as needed) not to be taken more than once every 24 hours for 8 weeks Tadalafil 5 mg tablets every day for 8 weeks
DRUG	Tadalafil	5 mg tablets every day for 8 weeks
DRUG	Tadalafil	5 mg tablets every day for 8 weeks

Timeline

• Start date: 2020-06-03
• Primary completion: 2021-01-11
• Completion: 2021-04-01
• First posted: 2020-04-24
• Last updated: 2020-04-24